Philip D Cutter, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 24 University Ln, Manchester, MA 01944 Phone: 978-526-1012 |
News Archive
The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.
Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants.
The number of new HIV diagnoses in the UK has fallen to a record low since 2000, according to a new report by Public Health England.
One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance - obtained from a coral-reef inhabiting cyanobacterium - appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases.
› Verified 2 days ago